Press release
Synovial Sarcoma Market to Reach US$ 111.9 Million by 2033, at CAGR of 4% from 2023 to 2033, IMARC Group
How big is the market for synovial sarcoma?
According to IMARC Group, in 2022, the total value of the seven major markets (7MM) for synovial sarcoma market amounted to US$ 72.4 Million. Looking forward, these markets are anticipated to reach US$ 111.9 Million by 2033, at a growth rate (CAGR) of 4% from 2023-2033.
Request for a Sample Report: https://www.imarcgroup.com/synovial-sarcoma-market/requestsample
What is synovial sarcoma?
Synovial sarcoma represents a type of soft tissue sarcoma, which is a cancer that develops in the body's connective tissues, including blood vessels, muscles, fat, etc. The most common locations are tendons in the arms or legs and near joints, but they can also occur in other parts of the body, like the chest and abdomen. The symptoms of synovial sarcoma include unexplained weight loss, stiffness, limited range of motion in joints, etc. Diagnosing synovial sarcoma generally involves a combination of medical imaging procedures and a biopsy of the suspicious area. Several imaging tests, such as X-rays, ultrasounds, MRIs, CT scans, etc., aid in identifying the location, size, and characteristics of the tumor.
Explore the Full Report with Table of Contents: https://www.imarcgroup.com/synovial-sarcoma-market
What are the key drivers and trends in the synovial sarcoma market?
The elevating cases of genetic mutations that affect genes involved in differentiation, cell growth, and apoptosis are primarily augmenting the synovial sarcoma market. Besides this, the rising adoption of immune checkpoint inhibitors, including pembrolizumab and nivolumab, which block proteins that inhibit the immune system's ability to recognize and attack cancer cells, is further propelling the market growth. Moreover, the escalating usage of radiofrequency ablation, a minimally invasive procedure that uses heat to destroy cancer cells for treating synovial sarcoma, is acting as another significant growth-inducing factor.
Additionally, numerous leading players are increasingly investing in R&D activities to introduce targeted drugs and therapies that target specific molecules involved in the formation and growth of cancer cells. This, in turn, is also contributing to the market growth. Furthermore, the continuous advancements in MRI technology, including the launch of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced MRI (DCE-MRI), which offer better visualization of tumor margins, detection of distant metastasis, and invasion of adjacent structures, are projected to fuel the synovial sarcoma market in the coming years.
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033
Countries Included:
United States
Germany
France
United Kingdom
Italy
Spain
Japan
Analysis Covered Across Each Country
Historical, current, and future epidemiology scenario
Historical, current, and future performance of the synovial sarcoma market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the synovial sarcoma market
Reimbursement scenario in the market
In-market and pipeline drugs
In-Market Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status
Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/request?type=report&id=7518&flag=C
How This Report Can Help You:
The report on synovial sarcoma market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the synovial sarcoma market.
The synovial sarcoma market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
Our report on the synovial sarcoma market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.
Browse Our Latest Healthcare Research Report:
Rheumatoid Arthritis Market Report 2023-2033: https://www.imarcgroup.com/rheumatoid-arthritis-market
Hypertrophic Scar Market Report 2023-2033: https://www.imarcgroup.com/hypertrophic-scar-market
Neuroblastoma Market Report 2023-2033: https://www.imarcgroup.com/neuroblastoma-market
Hepatitis C Market Report 2023-2033: https://www.imarcgroup.com/hepatitis-c-market
Key Questions Answered in this Report:
How has the synovial sarcoma market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the synovial sarcoma market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the synovial sarcoma market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
About Us: -
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Synovial Sarcoma Market to Reach US$ 111.9 Million by 2033, at CAGR of 4% from 2023 to 2033, IMARC Group here
News-ID: 3127757 • Views: …
More Releases from IMARC Group
Automotive Control Cables Manufacturing Plant Setup Report 2025: Machinery, Raw …
Automotive control cables are essential components used to transmit mechanical force in vehicles, enabling the smooth operation of various systems such as brakes, clutches, accelerators, gear shifts, and seating mechanisms. These cables are designed for durability, flexibility, and high performance under diverse driving conditions. Their demand is directly linked to the growth of the automotive industry, aftermarket sales, and increasing consumer preference for enhanced driving comfort and safety.
Setting up an…
Halal Cosmetics Market Size, Trends, Key Players, Opportunity and Forecast 2025- …
IMARC Group, a leading market research company, has recently released a report titled "Halal Cosmetics Market Size, Share, Trends and Forecast by Type, Distribution Channel, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the global halal cosmetics market size, trends, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Halal Cosmetics Market Highlights:
• Halal Cosmetics Market…
Comprehensive Castor Oil Processing Plant Project Report 2025: Setup Guide, Econ …
Castor oil is a versatile vegetable oil extracted from the seeds of the Ricinus communis plant. It is widely used in pharmaceuticals, cosmetics, food processing, lubricants, paints, coatings, and biodiesel production owing to its unique chemical properties, including high ricinoleic acid content. Castor oil derivatives also serve as key raw materials in the polymer, chemical, and industrial sectors.
Establishing a castor oil processing plant involves steps such as seed cleaning, dehulling,…
Honey Processing Plant Report 2025: Capital Investment, Operating Expenses and M …
Honey is a natural sweetener produced by honeybees and is valued for its nutritional, medicinal, and industrial applications. It contains antioxidants, enzymes, vitamins, and minerals that make it a popular ingredient in food and beverages, pharmaceuticals, cosmetics, and personal care products. Processed honey is widely consumed as a sweetener, used in bakery and confectionery items, beverages, dietary supplements, and skincare formulations.
Setting up a honey processing plant involves operations such as…
More Releases for Synovial
Synovial Sarcoma Market Clinical Advancements and Commercial Forecast
Synovial sarcoma is a rare, aggressive soft tissue cancer that typically arises near the joints of the arm or leg but can occur in other parts of the body. Although it accounts for less than 10% of all soft tissue sarcomas, synovial sarcoma often affects young adults and adolescents, making it a critical area of oncology research. Due to limited treatment options and poor survival outcomes, there has been an…
Synovial Sarcoma Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Synovial Sarcoma Pipeline Insight, 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial Sarcoma pipeline landscape. It covers the Synovial Sarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Synovial Sarcoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Synovial…
Synovial Sarcoma Market Size, Share, Report and Forecast 2024-2032
The synovial sarcoma market size is anticipated to grow at a CAGR of 4% during the forecast period of 2024-2032, driven by increasing research activities in targeted therapy development.
Synovial Sarcoma: Introduction
Synovial sarcoma is a rare and aggressive type of soft tissue cancer, primarily affecting young adults. It often arises near large joints, especially the knees, though it can occur anywhere in the body. Despite its name, it's not related to…
Synovial Sarcoma Market Size, Trends, Industry Value and Latest Insights Till 20 …
What is the market size of synovial sarcoma?
The synovial sarcoma market reached a value of US$ 75.3 Million in 2023 and expected to reach US$ 114.0 Million by 2034, exhibiting a growth rate (CAGR) of 3.84% during 2024-2034.
Request for a Sample of this Report: https://www.imarcgroup.com/synovial-sarcoma-market/requestsample
Synovial Sarcoma Market Trends:
Synovial sarcoma is a rare and aggressive form of soft tissue cancer that primarily affects young adults. Despite its rarity, the market for…
Synovial Sarcoma Market Analysis: Growth, Trends, and Key Players
The Synovial Sarcoma Market is set for substantial expansion, with an anticipated Compound Annual Growth Rate (CAGR) of 4% during the forecast period spanning from 2024 to 2032. This growth can be attributed to various factors such as the increasing incidence of synovial sarcoma, advancements in medical technology, and the development of targeted therapies. In this comprehensive blog post, we will provide an in-depth overview of the Synovial Sarcoma Market,…
Synovial Sarcoma Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Synovial Sarcoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Synovial Sarcoma, historical and forecasted epidemiology as well as the Synovial Sarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Synovial Sarcoma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Synovial Sarcoma market size…
